Jiří Cerman

629 total citations
10 papers, 171 citations indexed

About

Jiří Cerman is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jiří Cerman has authored 10 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Cognitive Neuroscience and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jiří Cerman's work include Dementia and Cognitive Impairment Research (4 papers), Medical Imaging Techniques and Applications (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Jiří Cerman is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Medical Imaging Techniques and Applications (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Jiří Cerman collaborates with scholars based in Czechia, United States and United Kingdom. Jiří Cerman's co-authors include Jakub Hort, Jan Laczó, Martin Vyhnálek, Kateřina Sheardová, Ross Andel, Zuzana Nedelská, John L. Woodard, Gill Farrar, Ondřej Lerch and Laurence Dricot and has published in prestigious journals such as Brain Research, Psychopharmacology and Current Opinion in Structural Biology.

In The Last Decade

Jiří Cerman

9 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiří Cerman Czechia 7 93 72 63 25 21 10 171
Natasha Rajah Canada 2 48 0.5× 56 0.8× 74 1.2× 26 1.0× 40 1.9× 5 225
Gustav Mårtensson Sweden 9 81 0.9× 57 0.8× 88 1.4× 14 0.6× 18 0.9× 14 189
Chuang‐Kuo Wu United States 5 40 0.4× 74 1.0× 36 0.6× 61 2.4× 38 1.8× 13 198
Simon Kang Seng Ting Singapore 11 111 1.2× 89 1.2× 82 1.3× 15 0.6× 25 1.2× 37 327
Danielle V. Mayblyum United States 6 131 1.4× 71 1.0× 74 1.2× 22 0.9× 16 0.8× 9 202
Joseph Giorgio United States 10 81 0.9× 59 0.8× 118 1.9× 22 0.9× 17 0.8× 23 232
Seqian Wang Canada 5 82 0.9× 109 1.5× 65 1.0× 14 0.6× 27 1.3× 12 175
Sinead Gaubert France 5 50 0.5× 56 0.8× 134 2.1× 24 1.0× 14 0.7× 10 209
Charles D. Chen United States 8 64 0.7× 71 1.0× 74 1.2× 26 1.0× 38 1.8× 14 184
Lisa Quenon Belgium 9 98 1.1× 96 1.3× 93 1.5× 16 0.6× 25 1.2× 25 215

Countries citing papers authored by Jiří Cerman

Since Specialization
Citations

This map shows the geographic impact of Jiří Cerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Cerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Cerman more than expected).

Fields of papers citing papers by Jiří Cerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Cerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Cerman. The network helps show where Jiří Cerman may publish in the future.

Co-authorship network of co-authors of Jiří Cerman

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Cerman. A scholar is included among the top collaborators of Jiří Cerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Cerman. Jiří Cerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Angelucci, Francesco, et al.. (2024). Integrating AI in fighting advancing Alzheimer: diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials. Current Opinion in Structural Biology. 87. 102857–102857. 8 indexed citations
2.
Matušková, Veronika, Dylan J. Jester, Václav Maťoška, et al.. (2024). Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms. Alzheimer s Research & Therapy. 16(1). 21–21. 8 indexed citations
3.
Cerman, Jiří, et al.. (2022). New pharmacological options in the treatment of Alzheimer‘s disease. Česká a slovenská neurologie a neurochirurgie. 85/118(6).
4.
Hanseeuw, Bernard, Laurence Dricot, Lisa Quenon, et al.. (2020). Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 302–310. 47 indexed citations
5.
Cerman, Jiří, et al.. (2020). Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity. Česká a slovenská neurologie a neurochirurgie. 83/116(2). 173–179. 6 indexed citations
6.
Sheardová, Kateřina, Martin Vyhnálek, Zuzana Nedelská, et al.. (2019). Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic. BMJ Open. 9(12). e030379–e030379. 34 indexed citations
7.
Cerman, Jiří, Ross Andel, Jan Laczó, et al.. (2017). Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease. Current Alzheimer Research. 15(3). 219–228. 33 indexed citations
8.
Laczó, Jan, Hana Marková, Ivana Gažová, et al.. (2016). Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans. Psychopharmacology. 234(4). 535–547. 24 indexed citations
9.
10.
Laczó, Jan, Ross Andel, Kamil Vlček, et al.. (2013). P2–291: The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment. Alzheimer s & Dementia. 9(4S_Part_11). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natasha Rajah Breakdown of academic impact, for papers by Gustav Mårtensson Breakdown of academic impact, for papers by Chuang‐Kuo Wu Breakdown of academic impact, for papers by Simon Kang Seng Ting Breakdown of academic impact, for papers by Danielle V. Mayblyum Breakdown of academic impact, for papers by Joseph Giorgio Breakdown of academic impact, for papers by Seqian Wang Breakdown of academic impact, for papers by Sinead Gaubert Breakdown of academic impact, for papers by Charles D. Chen Breakdown of academic impact, for papers by Lisa Quenon
Rankless by CCL
2026